|
|
Article: Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics
- Article from:
- Zacks Investment Research -
- Article date:
- November 10, 2009
- Author:
CopyrightCopyright 2009 Zacks Investment Research. (Hide copyright information)
|
Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics
For Immediate Release
Chicago, IL – November 10, 2009 – Zacks.com announces the latest Industry Outlook. Today, Zacks Equity Research discusses the Big Pharma & Biotech sector, including
Alcon
(
ACL
),
Novartis
(
NVS
),
Gilead Sciences
(
GILD
),
Biogen Idec
(
BIIB
) and
Acorda Therapeutics
(
ACOR
).
A synopsis of today’s Industry Outlook is presented below. The full article can be read at
http://www.zacks.com/stock/news/27081/Big+Pharma+and+Biotech
.
In the pharma space, we are positive on stocks like
Alcon
(
ACL
) and
Novartis
(
NVS
). We believe ...